Proteolytic activation of complement proteins C3 and C5 is known to occur in association with thrombus formation, and activators of both classical and alternative complement pathways can initiate platelet secretion and accelerate blood clotting. The research described in this Proposal aims to deduce the molecular pathways leading to proteolytic activation of C3 and C5 at the surface of stimulated platelets, and to investigate the role of the C3/C5-convertase reaction in expression of platelet procoagulant activity. In this Project we will use gel-fil-tered human platelets and purified proteins of the human complement and coagulation systems in experiments that aim: 1) to identify which components of the AP or CP convertase reaction directly initiate platelet secretion and expression of platelet prothrombinase activity; 2) to identify the signal-transduction pathways involved in platelet triggering mediated by C3/C5-convertases or their activated products; 3) to determine the topological distribution of C3b on the platelet surface, and its relationship to platelet activation; 4) to deduce the mechanism by which platelet activation alters the regulatory control of the CP and AP C3/C5-convertases at the cell surface ; 5) to determine how complement activation occurring spontaneously during collection and storage of platelets for transfusion affects platelet function and procoagulant activity. It is proposed that the data obtained from these experiments will significantly contribute to our understanding of the interrelationships of the cell-assembled enzyme reactions of the complement and hemostatic systems.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oklahoma Medical Research Foundation
Oklahoma City
United States
Zip Code
Bevers, E M; Wiedmer, T; Comfurius, P et al. (1995) The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 86:1983-91
Kojima, H; Newton-Nash, D; Weiss, H J et al. (1994) Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 94:2237-44
Chang, C P; Zhao, J; Wiedmer, T et al. (1993) Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 268:7171-8
Wiedmer, T; Hall, S E; Ortel, T L et al. (1993) Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192-6
Bevers, E M; Wiedmer, T; Comfurius, P et al. (1992) Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 79:380-8
Dahlback, B; Wiedmer, T; Sims, P J (1992) Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochemistry 31:12769-77
Gerrard, J M; Lint, D; Sims, P J et al. (1991) Identification of a platelet dense granule membrane protein that is deficient in a patient with the Hermansky-Pudlak syndrome. Blood 77:101-12
Gilbert, G E; Sims, P J; Wiedmer, T et al. (1991) Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266:17261-8
Sims, P J; Wiedmer, T (1991) The response of human platelets to activated components of the complement system. Immunol Today 12:338-42
Wiedmer, T; Sims, P J (1991) Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood 78:2880-6

Showing the most recent 10 out of 11 publications